EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

06.07.10

The Gates Foundation-Connected GlaxoSmithKline Indirectly Paid Scientists to Exaggerate Vaccine Needs

Posted in Bill Gates, Intellectual Monopoly, Patents at 5:15 am by Dr. Roy Schestowitz

GlaxoSmithKline logo

Summary: The philanthrocapitalist establishment whose Head of Global Health comes from GlaxoSmithKline has its work put to great scrutiny

THE Gates Foundation does not get much of a break because more and more people are beginning to understand its interests. It’s more complex than just “charity” as profit is being made without the foundation ever been taxed like a normal investor.

Today we turn our sceptical eye to the issue of patents and how the Gates Foundation promotes them. There is no question about the fact that Africa suffers from deadly diseases and Gates’ endeavours there are mostly commendable [1, 2]. It is a short-term solution which probably works well for both sides.

“The Gates Foundation acts as somewhat of a PR shim that intervenes where patents interfere/intersect with human toll.”What ought to be better understood is Bill Gates’ close relationship and interpersonal ties with the world’s largest pharmaceutical companies, which even work well inside the Gates Foundation (holding key positions). The Gates Foundation acts as somewhat of a PR shim that intervenes where patents interfere/intersect with human toll. It’s a marriage of convenience because the price of life is the route to big profits.

The following new report from The Guardian reveals that flu experts were indirectly being paid by pharmaceutical giants in order to overplay the risk of swine flu and thus increase sales of vaccines. GlaxoSmithKline (GSK) is mentioned among the culprits. [via Richard stallman]

Report condemns swine flu experts’ ties to big pharma

Scientists who drew up the key World Health Organisation guidelines advising governments to stockpile drugs in the event of a flu pandemic had previously been paid by drug companies which stood to profit, according to a report out today.

An investigation by the British Medical Journal and the Bureau of Investigative Journalism, the not-for-profit reporting unit, shows that WHO guidance issued in 2004 was authored by three scientists who had previously received payment for other work from Roche, which makes Tamiflu, and GlaxoSmithKline (GSK), manufacturer of Relenza.

City analysts say that pharmaceutical companies banked more than $7bn (£4.8bn) as governments stockpiled drugs. The issue of transparency has risen to the forefront of public health debate after dramatic predictions last year about a swine flu pandemic did not come true.

GSK was mentioned by us earlier today. We promised to revisit the subject because according to Portfolio.com, not only does the Gates Foundation have staff from GSK but it also has power over GSK:

The Bill & Melinda Gates Foundation was a driving force behind GlaxoSmithKline Plc’s decision to share propietary drug research for fighting malaria, the Puget Sound Business Journal reports.

That’s the same GSK which corrupted science in order to increase sales. That’s the same GSK which brought to the Gates Foundation its Head of Global Health, who bullies researchers. Gates Keepers writes about those patented drugs which the Gates Foundation is promoting:

Read this carefully: “so that all the people who are smart about the disease are to some degree on the same side, working together.” Here is a fatal flaw. Gates thinks that you can define “all the people who are smart about the disease” and invite them to work together. He and his staff wouldn’t know how to begin to find “all the people”. They are elite technocrats. How many people LIVING with the disease are working together on his elite panels?

This whole “parenthood” role which the Gates Foundation has been taking for years is sometimes just a tad insulting (patronising even) and it marginalises opposing/alternative points of view. Researchers often complain about that. Here is someone who is challenging their priorities:

Gates really, really likes the idea of using vertical funds to tackle (and eliminated) diseases one by one, rather than taking a more gradual, measured approach. Why do the big philanthropists (Gates, and by proxy, Buffet) prefer to take such a direct approach, circumventing governments?

The easiest explanation is through personality or experience: Gates is an entrepreneur, used to getting smart people in a room together to solve problems; private solutions for important problems. Governments have, if anything, been a source of irritation for him, lobbing the occasional anti-trust action at Microsoft.

[...]

I think it’s probably unrealistic to expect the Gates Foundation to start up a health SWAp anytime soon – the same factors that led to its creation will always drive it to tackle problems the way it does. What we should hope (and push) for is a commitment to “do no harm.” This means reverting to practices that do not distort health objectives on the ground (i.e. internal brain drain of qualified health staff, shifting the debate away from enforcing health systems to tackling single diseases). Working on vaccines, either through direct funding or advance market commitments, is a an example of high risk but less distortionary practice. The huge sums of money the Foundation juggles could also be used to create incentives for more general research into fighting tropical maladies, and then subsequently subsidise the price for needy countries.

Here is another new example from NYTimes.com. It’s very relevant to the above example.

“iBio and Fraunhofer USA Center for Molecular Biotechnology Enter Agreement to Provide Global Access for Bill & Melinda Gates Foundation Vaccines,” says the title of this new press release.

iBio, Inc. and the Fraunhofer USA Center for Molecular Biotechnology (CMB) announced today an agreement which provides a license of iBio’s proprietary technology to CMB for the development and manufacture of Global Health Vaccines for, and financed by, the Bill & Melinda Gates Foundation.

To avoid misunderstandings, the problem here is not vaccinations. Immunology and drugs are important and often vital for the saving of lives, but the economics here are a tricky operation that leaves the public out in the dark. The drugs industry is not just another industry like IT. The drug industry is massive and that’s where the big money is. Gates has investments in this industry, so it’s in his interest to promote it. Another related area is biotechnology, where Monsanto got itself a nice monopoly on the food chain. “Bill Gates reveals support for GMO eg,” says this headline from last year (one that we’ve just found and missed at the time, even though we already quite knowingly stated the facts [1, 2, 3, 4, 5, 6, 7, 8]).

As it has come to dominate the agenda for reshaping African agriculture over the years, the Bill and Melinda Gates Foundation has been very careful not to associate itself too closely with patent-protected biotechnology as a panacea for African farmers.

True, the foundation named 25-year Monsanto veteran Rob Horsch to the position of “senior program officer, focusing on improving crop yields in sub-Saharan Africa.”

Yet its flagship program for African ag, the Alliance for a Green Revolution in Africa (AGRA), explicitly distances itself from GMOs. “AGRA does not fund the development of GMOs,” the organization’s Web site states.

But AGRA — co-funded by the Rockefeller Foundation, proud sponsor of the original Green Revolution — is just part of what Gates does around African ag. What precisely is the foundation getting up to over there? Is it pushing GMOs on African smallholder farms?

Earlier on we wrote about GSK inside the Gates Foundation (Head of Global Health), but what many people overlook is that fact that there are Monsanto employees inside the Gates Foundation. They use the Gates Foundation as a seemingly ‘charitable’ lobby vehicle through which to advance the companies’ objectives, often at the expense of the public (which pays government tax to be funneled into patents on drugs for the developing world). It’s a simple matter of economics, creating scarcity with patents while profiting from massive tax-free investments.

There is another couple of new articles worth paying attention to:

Critics castigate Gastes Foundation on policy demands; India launches native H1N1 vaccines;

[...]

While the Gates Foundation has been widely lauded for its work on a wide range of initiatives, including financing research on new vaccines to guard against common killers in developing nations, some critics have emerged to caution against the foundation’s demands to “toe the line” on its position in policy debates.

Watch another man from the Gates Foundation offering “farming aid” (possibly a veiled reference to GMO):

Prior to joining the Obama Administration, Shah served as director of Agricultural Development in the Global Development Program at the Bill and Melinda Gates Foundation. In his seven years with the Gates Foundation, Shah served as the Foundation’s director of Strategic Opportunities and as deputy director of policy and finance for the Global Health Program.

They are getting increasingly connected to politics. Last week in The Times of India:

Obama appoints Indian-American to head U.S National Science Foundation

[...]

Clinton has Rajiv Shah, a former Gates Foundation executive and health expert, heading the USAID.

Clinton is connected to Bill Gates in ways that we explained before. When it comes to the Gates Foundation, former staff is often pursuing similar agendas after departure. To quote this new press release:

Academic Pharmacy Continues to Expand its Horizons at 2010 AACP Annual Meeting

[...]

He was the first business executive to serve as a public school superintendent and was the first executive director for the Bill & Melinda Gates Foundation.

This probably brings us to the subject of our next post, which says more about Gates Foundation influence on public schools [1, 2, 3, 4, 5].

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. French Politician Richard Yung Tells the Government About Abuses at the European Patent Office (EPO)

    The subject of EPO scandals has once again landed in French politics, just a couple of months since it last happened



  2. The Sickness of the EPO – Part II: Background Information and Insights

    With a privatised, in-house (sometimes outsourced and for-profit) force for surveillance, policing, justice, public relations and now medical assessment (mere vassals or marionettes of the management) the EPO serves to show that it has become indistinguishable from North Korea, where the Supreme Leader gets to control every single aspect (absolutely no separation of powers)



  3. EPO Cartoon/Caricature by KrewinkelKrijst

    A new rendition by Dutch cartoonist and illustrator KrewinkelKrijst



  4. Inverting Narratives: IAM 'Magazine' Paints Massive Patent Bully Microsoft (Preying on the Weak) as a Defender of the Powerless

    Selective coverage and deliberate misinterpretation of Microsoft's tactics (patent settlement under threat, disguised as "pre-installation of some of the US company’s software products") as seen in IAM almost every week these days



  5. The Sickness of the EPO – Part I: Motivation for New Series of Articles

    An introduction or prelude to a long series of upcoming posts, whose purpose is to show governance by coercion, pressure, retribution and tribalism rather than professional relationship between human beings at the European Patent Office (EPO)



  6. Insensitivity at the EPO’s Management – Part VII: EPO Hypocrisy on Cancer and Lack of Feedback to and From ECPC

    The European Cancer Patient Coalition (ECPC), which calls itself "the largest European cancer patients' umbrella organisation," fails to fulfill its duties, says a source of ours, and the EPO makes things even worse



  7. Links 21/2/2017: KDE Plasma 5.9.2 in Chakra GNU/Linux, pfSense 2.3.3

    Links for the day



  8. EPO Caricature: Battistelli's Wall

    Battistelli's solution to everything at the EPO is exclusion and barriers



  9. The 'New' Microsoft is Still Acting Like a Dangerous Cult in an Effort to Hijack and/or Undermine All Free/Open Source Software

    In an effort to combat any large deployment of non-Microsoft software, the company goes personal and attempts to overthrow even management that is not receptive to Microsoft's agenda



  10. PTAB Petitioned to Help Against Patent Troll InfoGation Corp., Which Goes After Linux/Android OEMs in China

    A new example of software patents against Free software, or trolls against companies that are distributing freedom-respecting software from a country where these patents are not even potent (they don't exist there)



  11. Links 20/2/2017: Linux 4.10, LineageOS Milestone

    Links for the day



  12. No, Doing Mathematical Operations on a Processor Does Not Make Algorithms Patent-Eligible

    Old and familiar tricks -- a method for tricking examiners into the idea that algorithms are actual machines -- are being peddled by Watchtroll again



  13. Paid-for UPC Proponent, IAM 'Magazine', Debunked on UPC Again

    The impact of the corrupted (by EPO money) media goes further than one might expect and even 'borrows' out-of-date news in order to promote the UPC



  14. Lack of Justice in and Around the EPO Drawing Scrutiny

    The status of the EPO as an entity above the law (in Germany, the Netherlands, Switzerland and so on) is becoming the subject of press reports and staff is leaving in large numbers



  15. Links 19/2/2017: GParted 0.28.1, LibreOffice Donations Record

    Links for the day



  16. The EPO is Becoming an Embarrassment to Europe and a Growing Threat to the European Union

    The increasingly pathetic moves by Battistelli and the ever-declining image/status of the EPO (only 0% of polled stakeholders approve Battistelli's management) is causing damage to the reputation of the European Union, even if the EPO is not a European Union organ but an international one



  17. Patent Misconceptions Promoted by the Patent Meta-Industry

    Cherry-picking one's way into the perception of patent eligibility for software and the misguided belief that without patents there will be no innovation



  18. As the United States Shuts Its Door on Low-Quality Patents the Patent Trolls Move to Asia

    Disintegration of Intellectual Ventures (further shrinkage after losing software patents at CAFC), China's massive patent bubble, and Singapore's implicit invitation/facilitation of patent trolls (bubble economy)



  19. Links 17/2/2017: Wine 2.2, New Ubuntu LTS

    Links for the day



  20. Bad Advice From Mintz Levin and Bejin Bieneman PLC Would Have People Believe That Software Patents Are Still Worth Pursuing

    The latest examples of misleading articles which, in spite of the avalanche of software patents in the United States, continue to promote these



  21. Patents Are Not Property, They Are a Monopoly, and They Are Not Owned But Temporarily Granted

    Patent maximalism and distortion of concepts associated with patents tackled again, for terminology is being hijacked by those who turned patents into their "milking cows"



  22. SoftBank Group, New Owner of ARM, Could Potentially Become (in Part) a Patent Troll or an Aggressor Like Qualcomm

    SoftBank grabbed headlines (in the West at least) when it bought ARM, but will it soon grab headlines for going after practicing companies using a bunch of patents that it got from Inventergy, ARM, and beyond?



  23. Technicolor, Having Turned Into a Patent Troll, Attacks Android/Tizen/Linux With Patents in Europe

    Technicolor, which a lot of the media portrayed as a patent troll in previous years (especially after it had sued Apple, HTC and Samsung), is now taking action against Samsung in Europe (Paris, Dusseldorf and Mannheim)



  24. Michelle Lee is Still “in Charge” of the US Patent System

    Contrary to a malicious whispering campaign against Lee (a coup attempt, courtesy of patent maximalists who make a living from mass litigation), she is still in charge of the USPTO



  25. Our Assessment: EPO Wants a Lot of Low-Quality Patents and Low-Paid Staff With UPC (Prosecution Galore)

    The European Patent Office seems to be less interested in examination and more interested in facilitating overzealous prosecution all across Europe and beyond; The Administrative Council has shown no signs that it is interested in profound changes, except those proposed by Battistelli in the face of growing resistance from staff and from ordinary stakeholders



  26. Links 16/2/2017: HITMAN for GNU/Linux, Go 1.8

    Links for the day



  27. Yet More Complaints About the European Patent Office in the Bavarian Regional Government

    Some German politicians do care about the welfare of EPO staff, a lot more so than the EPO's management that is actively crushing this staff



  28. EPO Staff Representatives to Escalate Complaint About Severe Injustices to the EPO's Secretive Board 28

    In a new letter to President Benoît Battistelli it is made abundantly apparent -- however politely -- that Battistelli's gross abuses could further complicate things for Battistelli, who is already embroiled in a fight with his predecessor, Roland Grossenbacher



  29. New Survey Reveals That High Patent Quality, or Elimination of Bad Patents, is Desirable to Patent Holders

    A new survey from Bloomberg BNA and AIPLA reveals that the Patent Trial and Appeal Board (PTAB), which still grows in prominence, is supported by people who have themselves gotten patents (not those who are in the bureaucracy of patents and self-serving politics)



  30. Open Patent Office is Not the Solution; Ending Software Patents is the Solution

    Our remarks about the goals and methods of the newly-established Open Patent Office and what is instead needed in order to combat the menace that threatens software development


CoPilotCo

RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

CoPilotCo

Recent Posts